Re:Diagnostic Pathology
Hello DT! Didn't know that one could quantify a journal's impact, but it is no surprise to me that you know this.
My take is that the co. had to settle with a low tier journal (after failed submission(s) to more prestigious ones) to get their data published, and the comments thus far (from Peter and JB118) further point out that the test itself is not going to light any fires in terms of revenue.
Thanks for the imput, and hope you are well,
aj